Its treatment portfolio covers ischemic stroke, aneurysm treatment, and innovations in vascular access and device delivery. The company offers thrombectomy devices for ischemic stroke, as well as aneurysm implants and treatments for vasospasm. Its work also includes coated flow diverters, which feature in the COATING randomized controlled trial; phenox reports published one-month safety results and final trial results.

Through its treatment resources, news, and clinical updates, phenox shares information about its technologies and research with healthcare professionals, including doctors and physicians, as well as non-medical audiences. The company also highlights funded projects and developments in evidence-based medicine, including the PROST trial. Visitors can access regulatory information and learn about the company’s careers, events, and product solutions. phenox is active internationally and provides resources through its website for people seeking information about neurovascular treatment options and the company’s ongoing work.